Association of co-medication quality with chemotherapy-related adverse drug reactions and survival in older colorectal cancer patients.

Li-Ju ChenThi Ngoc Mai NguyenDana Clarissa LaetschJenny Chang-ClaudeMichael HoffmeisterHermann BrennerBen Schöttker

Published in: The journals of gerontology. Series A, Biological sciences and medical sciences (2021)

Poor total co-medication quality was significantly associated with worse up to 5-year overall and CRC-specific survival. Randomized controlled trials are needed to test whether improved cancer co-medication management in older CRC patients prolongs survival.

Keyphrases

adverse drug
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
randomized controlled trial
prognostic factors
emergency department
systematic review
squamous cell carcinoma
study protocol
electronic health record
papillary thyroid
patient reported